Global Multiple Myeloma Disease Coverage Forecast and Market Analysis Report 2021: Comprehensive Collection of All Recent Events that has Affected the Market and Future Trends
12. April 2021 06:58 ET
|
Research and Markets
Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Disease Coverage Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering. Multiple myeloma is...
Rhizen Pharmaceuticals S.A. to present preclinical data of RP6530 (dual PI3K delta/gamma inhibitor) in Multiple Myeloma
18. November 2014 07:00 ET
|
Rhizen Pharmaceuticals SA
La Chaux-de-Fonds, Switzerland, Nov. 18, 2014 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A. announces a poster presentation for
RP6530, a novel dual PI3K delta/gamma inhibitor in Multiple
Myeloma.
...